Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study


Ozdemir N., Abali H., Vural M., YALÇIN Ş. , Oksuzoglu B., Civelek B., ...Daha Fazla

CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, sa.6, ss.1139-1147, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 74 Konu: 6
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s00280-014-2586-6
  • Dergi Adı: CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Sayfa Sayıları: ss.1139-1147

Özet

This phase II trial aimed to evaluate the efficacy and safety of docetaxel, cisplatin, and fluorouracil (DCF) combination in neoadjuvant setting in patients with locally advanced gastric adenocarcinoma.